Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Specka

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Deutsche Medizinische Wochenschrift (1946)|January 23, 2016
[Frequent non-medical cannabis use: health sequelae and effectiveness of detoxification treatment]Udo Bonnet, Michael Specka, Norbert Scherbaum
Psychiatrische Praxis|November 21, 2013
[Outcomes of comprehensive inpatient opiate detoxification in patients re-admitted to treatment within one year]Michael Specka, Kristina Lopez Gonzales, Norbert Scherbaum
Pharmacopsychiatry|November 23, 2023
Augmentation of Electroconvulsive Therapy with Oral Caffeine: A Retrospective Analysis of 40 Patients with Major DepressionPeter Nyhuis, Dorothea Mücke, Michael Specka, et al.
The International Journal on Drug Policy|March 10, 2009
Drug consumption facility as part of a primary health care centre for problem drug users - which clients are attracted?Norbert Scherbaum, Michael Specka, Johannes Bombeck, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 16, 2006
A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorderEugen Davids, Bernhard Kis, Michael Specka, et al.
Journal of Psychoactive Drugs|July 28, 2018
Long-Term Heavy Recreational Cannabis Use and Serum Delta-9-Tetrahydrocannabinol Levels are not Associated with an Impaired Liver Function in Cannabis DependentsUdo Bonnet, Ali Canbay, Michael Specka, et al.
Clinical Neuropharmacology|November 11, 2014
Use of disulfiram for alcohol relapse prevention in patients in opioid maintenance treatmentMichael Specka, Martin Heilmann, Bodo Lieb, et al.
Cannabis and Cannabinoid Research|October 27, 2021
Long-Term Frequent Cannabis Use and Related Serum Cannabinoid Levels Are Not Associated with Kidney DysfunctionUdo Bonnet, Thorsten Borda, Norbert Scherbaum, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|July 2, 2020
[Scientific Rationale for the Directive on Opioid Substitution Treatment of the German Medical Association: A Summary]Wilfried Kunstmann, Michael Specka, Norbert Wodarz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 8, 2022
Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping reviewUdo Bonnet, Michael Specka, Patrik Roser, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Deutsche Medizinische Wochenschrift (1946)|January 23, 2016
[Frequent non-medical cannabis use: health sequelae and effectiveness of detoxification treatment]Udo Bonnet, Michael Specka, Norbert Scherbaum
Psychiatrische Praxis|November 21, 2013
[Outcomes of comprehensive inpatient opiate detoxification in patients re-admitted to treatment within one year]Michael Specka, Kristina Lopez Gonzales, Norbert Scherbaum
Pharmacopsychiatry|November 23, 2023
Augmentation of Electroconvulsive Therapy with Oral Caffeine: A Retrospective Analysis of 40 Patients with Major DepressionPeter Nyhuis, Dorothea Mücke, Michael Specka, et al.
The International Journal on Drug Policy|March 10, 2009
Drug consumption facility as part of a primary health care centre for problem drug users - which clients are attracted?Norbert Scherbaum, Michael Specka, Johannes Bombeck, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 16, 2006
A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorderEugen Davids, Bernhard Kis, Michael Specka, et al.
Journal of Psychoactive Drugs|July 28, 2018
Long-Term Heavy Recreational Cannabis Use and Serum Delta-9-Tetrahydrocannabinol Levels are not Associated with an Impaired Liver Function in Cannabis DependentsUdo Bonnet, Ali Canbay, Michael Specka, et al.
Clinical Neuropharmacology|November 11, 2014
Use of disulfiram for alcohol relapse prevention in patients in opioid maintenance treatmentMichael Specka, Martin Heilmann, Bodo Lieb, et al.
Cannabis and Cannabinoid Research|October 27, 2021
Long-Term Frequent Cannabis Use and Related Serum Cannabinoid Levels Are Not Associated with Kidney DysfunctionUdo Bonnet, Thorsten Borda, Norbert Scherbaum, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|July 2, 2020
[Scientific Rationale for the Directive on Opioid Substitution Treatment of the German Medical Association: A Summary]Wilfried Kunstmann, Michael Specka, Norbert Wodarz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 8, 2022
Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping reviewUdo Bonnet, Michael Specka, Patrik Roser, et al.
Pageof 6